About Invivo Therapeutics Holdings Corp.

Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. Its clinical development program is the Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. The company was founded by Joseph P. Vacanti, Frank M. Reynolds, and Robert Langer in 2005 and is headquartered in Cambridge, MA.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a profit of 5.89$ per share.

The book value per share is -0.25$

Invivo Therapeutics Holdings Corp. website


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- - -11M - -11M 5.89 - - 9M -0.25 -12M - -12M